Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

COVID-19 vaccination challenges: A mini-review
Zeinab Mohseni Afshar, Mohammad Barary, Rezvan Hosseinzadeh, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 9
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination
Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, et al.
Human Antibodies (2024) Vol. 32, Iss. 3, pp. 85-106
Closed Access | Times Cited: 1
Kinetics of SARS-CoV-2 antibody titers after booster vaccinations during an Omicron surge in Japan
Naomi Matsumoto, Ayako Sasaki, Tomoka Kadowaki, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126156-126156
Closed Access | Times Cited: 1
Immunomodulatory and Anti-Inflammatory Effects of Berberine in Lung Tissue and its Potential Application in Prophylaxis and Treatment of COVID-19
Amin F. Majdalawieh, Sarah M. Yousef, Imad A. Abu‐Yousef, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 5
Open Access | Times Cited: 8
Association Between Cycle Threshold Value and Vaccination Status Among Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Cases in Ontario, Canada, in December 2021
Saranyah Ravindran, Jonathan B. Gubbay, Kirby Cronin, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 4
Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey
José R. Mediavilla, Tara Lozy, Annie Lee, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1699-1699
Open Access | Times Cited: 4
Transmission of SARS-CoV-2 in a primary school setting with and without public health measures using real-world contact data: A modelling study
Lixiang Yan, Stella Talic, Holly Wild, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 6
Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, Japan
Hideki Tani, Noriko Inasaki, Shunsuke Yazawa, et al.
Japanese Journal of Infectious Diseases (2023) Vol. 76, Iss. 5, pp. 319-322
Open Access | Times Cited: 3
Molecular and Clinical Epidemiology of SARS-CoV-2 Infection Among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey
José R. Mediavilla, Tara Lozy, Annie Lee, et al.
(2023)
Open Access | Times Cited: 3
Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19
Renuka Roche, Nouha Odeh, Abhay Andar, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1963-1963
Open Access | Times Cited: 3
A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
Mengxin Zhang, Pin Zhang, Ying Liang, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1212-1224
Open Access | Times Cited: 5
Factors Associated to Community Practices Toward the COVID-19 Pandemic: A Cross-Sectional Study in Indonesia
Yanny Trisyani, Etika Emaliyawati, Aan Nuraeni, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 1901-1912
Open Access
COVID-19 Vaccine Breakthrough Infections and Compliance to Non-Pharmaceutical Public Health Interventions: A Nested Case-Control Study
Jesha Mundodan, Mohamed Sallam, Rejoice Puthuchira Ravi, et al.
Journal of Vaccines Immunology and Immunopathology (2024) Vol. 9, Iss. 1
Open Access
Evaluating the Relationship between Various Risk Factors and COVID-19 Incidence in People Living with HIV: A Cross-Sectional Study
Hamid Harandi, Esmaeil Mehraeen, Soudabeh Yarmohammadi, et al.
Current HIV Research (2024) Vol. 22, Iss. 3, pp. 195-201
Closed Access
Comparison of Clinical, Laboratory, and Radiological Symptoms of Patients Hospitalized in the COVID-19 Wards of Imam Reza Hospital in Mashhad During the First, Second, and Third Peaks of COVID-19
Hamed Ferdowsi Moghadam, Ali Shamshirian, Lida Jarahi, et al.
Shiraz E-Medical Journal (2024) Vol. 25, Iss. 9
Open Access
Assessment of “Knowledge, attitudes and practice” of the population of the Republic of Tajikistan regarding COVID-19
G. M. Muhsinzoda, M. M. Ruziev, YU.YU. MIRZOALIEV, et al.
Public Health (2024) Vol. 4, Iss. 3, pp. 78-89
Closed Access
Expression, purification and immunogenicity analyses of receptor binding domain protein of severe acute respiratory syndrome coronavirus 2 from delta variant.
Liqing Liu, Hong Chen, Ping Liu, et al.
PubMed (2024) Vol. 15, Iss. 12, pp. 657-663
Closed Access
A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional
Priyanka Pandit, Puneet Bhatt, Rima R. Sahay, et al.
Journal of Infection (2022) Vol. 85, Iss. 1, pp. e15-e17
Open Access | Times Cited: 3
Knowledge, attitudes, and behaviors regarding COVID-19 among hospitalized patients in Taizhou, China
Xiaoyan Wu, Chengwen Luo, Meixian Zhang, et al.
Journal of Public Health (2022) Vol. 32, Iss. 1, pp. 137-143
Open Access | Times Cited: 3
Neutralizing antibody levels and epidemiological information of patients with breakthrough COVID-19 infection in Toyama, Japan
Hideki Tani, Noriko Inasaki, Takahisa Shimada, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report
Karl Čiuoderis, Laura Pérez, Catalina Alvarez, et al.
Journal of Medical Case Reports (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 1
The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19
Yeşim Yıldız, Hasan Selçuk Özger, Ali Acar, et al.
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 2, pp. 118-126
Open Access | Times Cited: 1
Prevalence, Clinical Profile and Determinants of COVID-19 Vaccination and SARS-CoV-2 Breakthrough Infection in Douala, Cameroon
Arlette Flore Moguem Soubgui, Loick Pradel Kojom Foko, Elisée Libert Embolo Enyegue, et al.
Trends in Medical Research (2023) Vol. 18, Iss. 1, pp. 122-135
Open Access | Times Cited: 1
Emergence of Omicron BA.1 and BA.2 variants and concern over vaccine breakthrough infection
Mahnoor Sukaina, Naba Ali, Marium Waheed, et al.
Annals of Medicine and Surgery (2022) Vol. 79
Open Access | Times Cited: 2
Household Transmission of SARS-CoV-2 in Bhutan
Jimba Jatsho, Dorji Pelzom, Sithar Dorji, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 2

Scroll to top